130 related articles for article (PubMed ID: 2672092)
21. MR imaging of focal splenic tumors.
Hahn PF; Weissleder R; Stark DD; Saini S; Elizondo G; Ferrucci JT
AJR Am J Roentgenol; 1988 Apr; 150(4):823-7. PubMed ID: 3279735
[TBL] [Abstract][Full Text] [Related]
22. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
[TBL] [Abstract][Full Text] [Related]
23. Regenerating nodules of liver cirrhosis: MR imaging.
Itai Y; Ohnishi S; Ohtomo K; Kokubo T; Yoshida H; Yoshikawa K; Imawari M
Radiology; 1987 Nov; 165(2):419-23. PubMed ID: 2821574
[TBL] [Abstract][Full Text] [Related]
24. 3-T MRI: usefulness for evaluating primary lung cancer and small nodules in lobes not containing primary tumors.
Yi CA; Jeon TY; Lee KS; Lee JH; Seo JB; Kim YK; Chung MJ
AJR Am J Roentgenol; 2007 Aug; 189(2):386-92. PubMed ID: 17646465
[TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance susceptibility-weighted imaging versus other imaging modalities in detecting splenic siderotic lesions.
Li C; Zhou D; Zhao J; Wang X; Mu W; Wang J
PLoS One; 2013; 8(9):e73626. PubMed ID: 24040004
[TBL] [Abstract][Full Text] [Related]
26. MR imaging of pancreatic changes in patients with transfusion-dependent beta-thalassemia major.
Midiri M; Lo Casto A; Sparacia G; D'Angelo P; Malizia R; Finazzo M; Montalto G; Solbiati L; Lagalla R; De Maria M
AJR Am J Roentgenol; 1999 Jul; 173(1):187-92. PubMed ID: 10397124
[TBL] [Abstract][Full Text] [Related]
27. Gamna-Gandy bodies.
Bernaerts A; Vanhoenacker FM; Op de Beeck B; De Schepper AM
JBR-BTR; 2001; 84(5):202. PubMed ID: 11757677
[No Abstract] [Full Text] [Related]
28. Regenerating nodules of liver cirrhosis: MR imaging with pathologic correlation.
Ohtomo K; Itai Y; Ohtomo Y; Shiga J; Iio M
AJR Am J Roentgenol; 1990 Mar; 154(3):505-7. PubMed ID: 2154911
[TBL] [Abstract][Full Text] [Related]
29. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
Martín J; Puig J; Falcó J; Donoso L; Rué M; Sentís M; Darnell A; Musulén E
Radiology; 1998 May; 207(2):325-30. PubMed ID: 9577476
[TBL] [Abstract][Full Text] [Related]
30. Value of phase-shift gradient-echo MR imaging in the differentiation of pelvic lesions with high signal intensity at T1-weighted imaging.
Yamashita Y; Torashima M; Hatanaka Y; Harada M; Sakamoto Y; Takahashi M; Miyazaki K; Okamura H
Radiology; 1994 Jun; 191(3):759-64. PubMed ID: 8184059
[TBL] [Abstract][Full Text] [Related]
31. MR imaging of spleen in beta-thalassemia major.
Papakonstantinou O; Drakonaki EE; Maris T; Vasiliadou A; Papadakis A; Gourtsoyiannis N
Abdom Imaging; 2015 Oct; 40(7):2777-82. PubMed ID: 26023008
[TBL] [Abstract][Full Text] [Related]
32. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
33. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
Yasumoto M; Shibuya H; Takeda M; Korenaga T
AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
[TBL] [Abstract][Full Text] [Related]
34. T2-weighted MR imaging of the abdomen: fast spin-echo vs conventional spin-echo sequences.
Catasca JV; Mirowitz SA
AJR Am J Roentgenol; 1994 Jan; 162(1):61-7. PubMed ID: 8273691
[TBL] [Abstract][Full Text] [Related]
35. "Hamartoma" of the spleen (splenoma) in children.
Abramowsky C; Alvarado C; Wyly JB; Ricketts R
Pediatr Dev Pathol; 2004; 7(3):231-6. PubMed ID: 15037946
[TBL] [Abstract][Full Text] [Related]
36. Septa in the liver of patients with chronic hepatic schistosomiasis japonica: MR appearance.
Monzawa S; Ohtomo K; Oba H; Nogata Y; Kachi K; Uchiyama G
AJR Am J Roentgenol; 1994 Jun; 162(6):1347-51. PubMed ID: 8191996
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
38. Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply.
Shinmura R; Matsui O; Kobayashi S; Terayama N; Sanada J; Ueda K; Gabata T; Kadoya M; Miyayama S
Radiology; 2005 Nov; 237(2):512-9. PubMed ID: 16244260
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular adenoma: MR imaging features with pathologic correlation.
Chung KY; Mayo-Smith WW; Saini S; Rahmouni A; Golli M; Mathieu D
AJR Am J Roentgenol; 1995 Aug; 165(2):303-8. PubMed ID: 7618545
[TBL] [Abstract][Full Text] [Related]
40. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]